社会医療法人北楡会 札幌北楡病院

社会医療法人北楡会

札幌北楡病院

予約専用

011-865-0201

予約受付時間

平日

9:00-12:00 13:30-16:00

  • 標準

  • 特大

学術活動状況

Academic activities

論文掲載情報(英文)

Yanagi M

Nelarabine-containing salvage therapy and conditioning regimen in transplants for pediatric T-cell acute lymphoblastic leukemia and lymphoma. International Journal of Hematology 119(3):327-333,2024

Sano H

Analysis of overweight/obese pediatric patients with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 study. International Journal of Hematology 119(6):745-754,2024

Sano H

Analysis of non-alcoholic fatty liver disease during induction therapy for B-cell precursor acute lymphoblastic leukemia in children and adolescents. Pediatrics and Neonatology 65(1):23-30,2024

Ogasawara M

Donor Lymphocyte Infusion for Relapsed Acute Leukemia or Myelodysplastic Syndrome after Hematopoietic Stem Cell Transplantation: A Single-Institute Retrospective Analysis. Intern Med. 2023 May 24. doi: 10.2169/internalmedicine.1714-23.

Sugita J

Posttransplant cyclophosphamide in unrelated and related peripheral blood stem cell transplantation from HLA-matched and 1 allele mismatched donor. Bone Marrow Transplant. 2023. DOI: 10.1038/s41409-023-02162-6

Imamura M

Role of loss and skew of X chromosome inactivation for developing myelodysplastic syndrome in patients with Klinefelter syndrome: A brief review of the literature. Leukemia Research Reports doi: 10.1016/j.lrr.2023.100396.

Imamura M

Medium-dose etoposide, cyclophosphamide and total body irradiation conditioning potentiates anti-leukemia immunity in adults with acute lymphoblastic leukemia without aggravating graft-versus-host disease. Cytotherapy 25(12):1251-1258,2023

Miki K

A case of Hodgkin lymphoma-type Richter syndrome presenting as small-intestinal perforation. International Journal of Hematology 118(6):766-771,2023

Matsushima S

Clinical Outcomes after One-day or Two-day Intervals in Conditioning Regimens for allo-HCT. J Pediatr Hematol Oncol 45(3):e378-e383,2023

Yanagi M

Development of nephrotic syndrome during immunosuppressive treatment for aplastic anaemia with monosomy 7 in a 16-year-old boy: A case report. J Paediatr Child Health 59(2):365-367,2023

Sano H

Intralobar Nephroblastomatosis Mimicking Wilms Tumor Treated with Chemotherapy after Removal of the Affected Kidney. Clinical Pediatric Hematology-Oncology 30(1):21-24,2023

Miura M

Temporary reduction of immunosuppression enhances production of anti-S antibody against severe acute respiratory syndrome coronavirus 2 after vaccination in kidney transplant recipients. International Journal of Urology 29(12):1505-1510,2022

Miura M

Initial experience of transurethral ultrasound ablation of the prostate in Asia. BJUI Compass.3(6):405-407,2022

Sano H

Analysis of long-term renal function in patients with malignant solid tumors: Retrospective analysis using the estimated glomerular filtration rate. Pediatrics International.64(1):e15373. doi: 10.1111/ped.15373.

Hori D

Hepatic cirrhosis after hematopoietic stem cell transplantation for neuroblastoma. Pediatrics International.64(1):e15267. doi: 10.1111/ped.15267.

Yanagi M

Early reconstitution of lymphocytes after allogenic hematopoietic stem cell transplantation affects chronic graft-versus-host disease. Pediatrics International.64(1):e15222. doi: 10.1111/ped.15222.

Matsushima S

Colorectal signet-ring cell carcinoma treated with FOLFOX plus panitumumab. Pediatrics International.64(1):e15374. doi: 10.1111/ped.15374.

Matsushima S

Successful treatment of steroid-dependent gastrointestinal acute graft-versus-host disease with mesenchymal stromal cells administered more than 100 days after allo-HCT. Blood Cell Therapy.5(3):27-30,2022

Yoshida S

The preceding hyponatremia is a useful hallmark for the diagnosis of HHV-6 encephalitis after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. doi: 10.1038/s41409-022-01843-y.

Imamura M

Hypothesis: can transfer of primary neoplasm-derived extracellular vesicles and mitochondria contribute to the development of donor cell-derived hematologic neoplasms after allogeneic hematopoietic cell transplantation? Cytotherapy.24(12):1169-1180,2022

1  2  3